In this project, we present a combination of two different technologies on the field of regenerative medicine and nanoparticles.
Related research. Artificial skin
The Tissue Engineering Research Group of the University of Granada managed to standardise the manufacturing process and quality control of this innovative skin substitute with improved resistance, consistency, elasticity and easy-handling.
Related research. Nanoparticles
The research area of Centauro Health Corporation (that includes OSI Health XXI and Biopraxis) has been working for years in the development of a suitable drug delivery system (DDS) for recombinant human epidermal growth factor (rhEGF).